SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Synergy Pharmaceuticals, Inc. Warrants (SGYPW)

SGYPW RSS Feed
Add SGYPW Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 8/24/2016 10:37:05 AM - Followers: 0 - Board type: Free - Posts Today: 0
Synergy Pharmaceuticals, Inc.

420 Lexington Avenue
Suite 2012
New York, NY 10170
United States
212-297-0020

http://www.synergypharma.com

ynergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic constipation GI disorders; and for the treatment of constipation-predominant irritable bowel syndrome GI disorders. The company is also developing SP-333, which is in Phase II clinical trials to treat opioid induced constipation, as well as in Phase Ib clinical trials to treat ulcerative colitis. The company has a research collaboration with BIND Therapeutics, Inc. to develop ACCURINS for treatment of a range of cells with novel therapeutic payloads. Synergy Pharmaceuticals Inc. is headquartered in New York, New York.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SGYPW
Current Price
Volume:
Bid Ask Day's Range
SureTrader
SGYPW News: Synergy Pharmaceuticals to Begin Trading on The NASDAQ Global Market 02/11/2013 05:00:00 AM
SGYPW News: Synergy Pharmaceuticals Added to the Russell 3000(R), Russell Global, and Russell Microcap Indexes 06/25/2012 09:15:00 AM
SGYPW News: Synergy Pharmaceuticals to Present at 2012 BIO International Convention 06/13/2012 09:15:00 AM
SGYPW News: Synergy Pharmaceuticals to Present Abstract at Digestive Disease Week 2012 05/15/2012 09:15:00 AM
SGYPW News: Synergy Pharmaceuticals Appoints Gail M. Comer, M.D. as Chief Medical Officer 05/02/2012 04:00:00 AM
PostSubject
#1   SGYPW bullish 0.57 stocktrademan 08/24/16 10:37:05 AM
PostSubject